Wockhardt Limited (NSE:WOCKPHARMA)
India · Delayed Price · Currency is INR 1,174.70
-14.80 (-1.24%)
Mar 30, 2026, 3:30 PM IST
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 191.04 billion as of March 30, 2026. Its market cap has decreased by -11.60% in one year.
Market Cap
191.04B
Enterprise Value
208.91B
Revenue
31.74B
Ranking
n/a
PE Ratio
868.37
Stock Price
1,174.70
Market Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 191.04B, an increase of 997.70%. That is a compound annual growth rate of 10.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 193.28B | -17.75% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 402.37B |
| Ajanta Pharma | 350.67B |
| Emcure Pharmaceuticals | 313.33B |
| Gland Pharma | 284.06B |
| Piramal Pharma | 190.63B |
| Eris Lifesciences | 185.77B |
| NATCO Pharma | 175.29B |
| Alembic Pharmaceuticals | 132.40B |